<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the period from October 1990 to December 1991, 23 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> were treated with recombinant tissue plasminogen activator (rt-PA) at a median of 205 min (range 78-355 min) after symptom <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this open pilot study rt-PA was given intravenously after an <z:hpo ids='HP_0011009'>acute</z:hpo> CT scan had not shown <z:hpo ids='HP_0011009'>acute</z:hpo> changes </plain></SENT>
<SENT sid="2" pm="."><plain>In 12 patients regional cerebral blood flow was measured intravenously using 99mTc-HMPAO before and within 24 h after thrombolytic therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Reperfusion of the ischemic area was obtained in 10 patients </plain></SENT>
<SENT sid="4" pm="."><plain>In these patients clinical improvement was greater the shorter the delay from symptom <z:hpo ids='HP_0003674'>onset</z:hpo> to initiation of treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Three of the 23 patients died, one of a parenchymatous <z:mp ids='MP_0008817'>hematoma</z:mp>, one of a large middle cerebral artery <z:mpath ids='MPATH_124'>infarct</z:mpath>, and one of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
</text></document>